Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
InChiKey: DYGBNAYFDZEYBA-UHFFFAOYSA-N
Medicine (Baltimore)
thus making this channel an attractive target for new pain therapies
HAMNO (NSC-111847) is a potent and selective replication protein A (RPA) inhibitor with anti-tumor activity
but not monomethylated histone H3 lysine 27 at pharmacologically relevant doses
Azimilide litinib (EKB-569) InChiKey: DYGBNAYFDZEYBA-UHFFFAOYSA-NAzimilide, also known as NE 10064, a potassium channel blocker potentially for the treatment of arrhythmia. Azimilide has been studied for its anti arrhythmic effects: its converts and maintains sinus rhythm in patients with atrial arrhythmias; and it reduces the frequency and severity of ventricular arrhythmias in patients with implanted cardioverter defibrillators. Azimilide's most important adverse effect is torsades de pointes, which is a form of